Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 487.21 Million USD | -9.43% |
| 2022 | 537.94 Million USD | -1.41% |
| 2021 | 545.61 Million USD | 77.7% |
| 2020 | 307.04 Million USD | -5.84% |
| 2019 | 326.08 Million USD | 4314.24% |
| 2018 | 7.38 Million USD | -91.69% |
| 2017 | 88.84 Million USD | -4.5% |
| 2016 | 93.02 Million USD | -6.97% |
| 2015 | 100 Million USD | -14.07% |
| 2014 | 116.37 Million USD | 138.94% |
| 2013 | 48.7 Million USD | -53.13% |
| 2012 | 103.91 Million USD | -28.55% |
| 2011 | 145.43 Million USD | -20.03% |
| 2010 | 181.86 Million USD | -15.47% |
| 2009 | 215.15 Million USD | -34.52% |
| 2008 | 328.57 Million USD | 1266.78% |
| 2007 | 24.04 Million USD | 350.44% |
| 2006 | 5.33 Million USD | -91.63% |
| 2005 | 63.75 Million USD | 1568.62% |
| 2004 | 3.82 Million USD | -53.84% |
| 2003 | 8.27 Million USD | -30.41% |
| 2002 | 11.89 Million USD | -53.98% |
| 2001 | 25.85 Million USD | 60.57% |
| 2000 | 16.09 Million USD | -36.95% |
| 1999 | 25.53 Million USD | -7.38% |
| 1998 | 27.56 Million USD | 179.53% |
| 1997 | 9.86 Million USD | 32.6% |
| 1996 | 7.43 Million USD | 61.68% |
| 1995 | 4.6 Million USD | 53.33% |
| 1994 | 3 Million USD | 76.47% |
| 1993 | 1.7 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 474.64 Million USD | -1.49% |
| 2024 Q1 | 481.81 Million USD | -1.11% |
| 2023 Q1 | 485.43 Million USD | -9.76% |
| 2023 Q3 | 490.2 Million USD | 0.7% |
| 2023 Q2 | 486.78 Million USD | 0.28% |
| 2023 Q4 | 487.21 Million USD | -0.61% |
| 2023 FY | 487.21 Million USD | -9.43% |
| 2022 Q3 | 561.96 Million USD | 0.07% |
| 2022 FY | 537.94 Million USD | -1.41% |
| 2022 Q1 | 543.95 Million USD | -0.3% |
| 2022 Q2 | 561.58 Million USD | 3.24% |
| 2022 Q4 | 537.94 Million USD | -4.27% |
| 2021 Q2 | 283.62 Million USD | -15.37% |
| 2021 Q3 | 547.28 Million USD | 92.96% |
| 2021 FY | 545.61 Million USD | 77.7% |
| 2021 Q1 | 335.11 Million USD | 9.14% |
| 2021 Q4 | 545.61 Million USD | -0.31% |
| 2020 Q2 | 494.99 Million USD | 4.55% |
| 2020 Q4 | 307.04 Million USD | -24.05% |
| 2020 Q3 | 404.26 Million USD | -18.33% |
| 2020 Q1 | 473.45 Million USD | 45.2% |
| 2020 FY | 307.04 Million USD | -5.84% |
| 2019 Q1 | 391.12 Million USD | 5194.77% |
| 2019 FY | 326.08 Million USD | 4314.24% |
| 2019 Q4 | 326.08 Million USD | 0.64% |
| 2019 Q2 | 357.65 Million USD | -8.56% |
| 2019 Q3 | 324 Million USD | -9.41% |
| 2018 Q2 | 124.6 Million USD | 44.56% |
| 2018 Q3 | 56.06 Million USD | -55.01% |
| 2018 Q4 | 7.38 Million USD | -86.82% |
| 2018 Q1 | 86.19 Million USD | -2.97% |
| 2018 FY | 7.38 Million USD | -91.69% |
| 2017 Q2 | 91.29 Million USD | -1.15% |
| 2017 Q3 | 89.91 Million USD | -1.52% |
| 2017 Q4 | 88.84 Million USD | -1.19% |
| 2017 Q1 | 92.36 Million USD | -0.72% |
| 2017 FY | 88.84 Million USD | -4.5% |
| 2016 FY | 93.02 Million USD | -6.97% |
| 2016 Q3 | 94.09 Million USD | -0.43% |
| 2016 Q4 | 93.02 Million USD | -1.13% |
| 2016 Q1 | 110.56 Million USD | 10.57% |
| 2016 Q2 | 94.5 Million USD | -14.53% |
| 2015 Q2 | 95.51 Million USD | -2.97% |
| 2015 Q1 | 98.44 Million USD | -15.41% |
| 2015 FY | 100 Million USD | -14.07% |
| 2015 Q4 | 100 Million USD | 0.0% |
| 2015 Q3 | 100 Million USD | 4.69% |
| 2014 Q2 | 144.27 Million USD | 235.9% |
| 2014 Q4 | 116.37 Million USD | 1.81% |
| 2014 FY | 116.37 Million USD | 138.94% |
| 2014 Q1 | 42.95 Million USD | -11.81% |
| 2014 Q3 | 114.29 Million USD | -20.78% |
| 2013 Q3 | 70.85 Million USD | -5.28% |
| 2013 FY | 48.7 Million USD | -53.13% |
| 2013 Q2 | 74.8 Million USD | -5.02% |
| 2013 Q4 | 48.7 Million USD | -31.26% |
| 2013 Q1 | 78.75 Million USD | -24.21% |
| 2012 Q4 | 103.91 Million USD | -17.92% |
| 2012 Q1 | 136.88 Million USD | -5.88% |
| 2012 Q2 | 128.4 Million USD | -6.2% |
| 2012 Q3 | 126.59 Million USD | -1.41% |
| 2012 FY | 103.91 Million USD | -28.55% |
| 2011 Q1 | 172.23 Million USD | -5.29% |
| 2011 FY | 145.43 Million USD | -20.03% |
| 2011 Q2 | 163.34 Million USD | -5.16% |
| 2011 Q3 | 153.25 Million USD | -6.18% |
| 2011 Q4 | 145.43 Million USD | -5.1% |
| 2010 FY | 181.86 Million USD | -15.47% |
| 2010 Q1 | 203.38 Million USD | -5.47% |
| 2010 Q2 | 204.12 Million USD | 0.36% |
| 2010 Q4 | 181.86 Million USD | -5.62% |
| 2010 Q3 | 192.7 Million USD | -5.6% |
| 2009 Q2 | 241.69 Million USD | -22.25% |
| 2009 Q4 | 215.15 Million USD | -3.61% |
| 2009 Q3 | 223.21 Million USD | -7.65% |
| 2009 Q1 | 310.85 Million USD | -5.39% |
| 2009 FY | 215.15 Million USD | -34.52% |
| 2008 FY | 328.57 Million USD | 1266.78% |
| 2008 Q1 | 417.42 Million USD | 1636.39% |
| 2008 Q2 | 379.19 Million USD | -9.16% |
| 2008 Q3 | 359.73 Million USD | -5.13% |
| 2008 Q4 | 328.57 Million USD | -8.66% |
| 2007 Q2 | 15.3 Million USD | 141.57% |
| 2007 FY | 24.04 Million USD | 350.44% |
| 2007 Q3 | 23.68 Million USD | 54.77% |
| 2007 Q1 | 6.33 Million USD | 18.68% |
| 2007 Q4 | 24.04 Million USD | 1.52% |
| 2006 Q1 | 71.57 Million USD | 12.27% |
| 2006 FY | 5.33 Million USD | -91.63% |
| 2006 Q2 | 58.28 Million USD | -18.57% |
| 2006 Q3 | 54.06 Million USD | -7.23% |
| 2006 Q4 | 5.33 Million USD | -90.13% |
| 2005 Q3 | 64.73 Million USD | 1025.58% |
| 2005 FY | 63.75 Million USD | 1568.62% |
| 2005 Q4 | 63.75 Million USD | -1.5% |
| 2005 Q2 | 5.75 Million USD | -2.54% |
| 2005 Q1 | 5.9 Million USD | 54.44% |
| 2004 Q1 | 7.02 Million USD | -15.12% |
| 2004 FY | 3.82 Million USD | -53.84% |
| 2004 Q4 | 3.82 Million USD | -39.96% |
| 2004 Q3 | 6.36 Million USD | 10.91% |
| 2004 Q2 | 5.73 Million USD | -18.33% |
| 2003 Q2 | 9.1 Million USD | -15.24% |
| 2003 Q1 | 10.73 Million USD | -9.72% |
| 2003 Q4 | 8.27 Million USD | -7.69% |
| 2003 FY | 8.27 Million USD | -30.41% |
| 2003 Q3 | 8.96 Million USD | -1.47% |
| 2002 Q4 | 11.89 Million USD | -46.35% |
| 2002 Q2 | 20.9 Million USD | 12.3% |
| 2002 Q1 | 18.61 Million USD | -28.0% |
| 2002 FY | 11.89 Million USD | -53.98% |
| 2002 Q3 | 22.17 Million USD | 6.08% |
| 2001 Q3 | 5 Million USD | -73.98% |
| 2001 FY | 25.85 Million USD | 60.57% |
| 2001 Q2 | 19.22 Million USD | -14.35% |
| 2001 Q1 | 22.44 Million USD | 39.44% |
| 2001 Q4 | 25.85 Million USD | 416.79% |
| 2000 FY | 16.09 Million USD | -36.95% |
| 2000 Q2 | 23.97 Million USD | 0.1% |
| 2000 Q4 | 16.09 Million USD | -22.21% |
| 2000 Q3 | 20.69 Million USD | -13.68% |
| 2000 Q1 | 23.95 Million USD | 228.08% |
| 1999 Q1 | 33.5 Million USD | 21.52% |
| 1999 Q4 | 7.3 Million USD | -76.07% |
| 1999 Q3 | 30.5 Million USD | -24.5% |
| 1999 FY | 25.53 Million USD | -7.38% |
| 1999 Q2 | 40.4 Million USD | 20.6% |
| 1998 FY | 27.56 Million USD | 179.53% |
| 1998 Q3 | 11.5 Million USD | -3.36% |
| 1998 Q4 | 27.56 Million USD | 139.71% |
| 1998 Q1 | 7.4 Million USD | -24.96% |
| 1998 Q2 | 11.9 Million USD | 60.81% |
| 1997 Q3 | 9.4 Million USD | 0.0% |
| 1997 Q2 | 9.4 Million USD | 0.0% |
| 1997 FY | 9.86 Million USD | 32.6% |
| 1997 Q1 | 9.4 Million USD | 26.39% |
| 1997 Q4 | 9.86 Million USD | 4.91% |
| 1996 Q2 | 6.7 Million USD | 21.82% |
| 1996 Q3 | 6.7 Million USD | 0.0% |
| 1996 FY | 7.43 Million USD | 61.68% |
| 1996 Q1 | 5.5 Million USD | 19.57% |
| 1996 Q4 | 7.43 Million USD | 11.01% |
| 1995 FY | 4.6 Million USD | 53.33% |
| 1995 Q2 | 4.4 Million USD | 57.14% |
| 1995 Q1 | 2.8 Million USD | -6.67% |
| 1995 Q3 | 3.5 Million USD | -20.45% |
| 1995 Q4 | 4.6 Million USD | 31.43% |
| 1994 FY | 3 Million USD | 76.47% |
| 1994 Q4 | 3 Million USD | 0.0% |
| 1994 Q2 | 2.3 Million USD | 4.55% |
| 1994 Q1 | 2.2 Million USD | 29.41% |
| 1993 FY | 1.7 Million USD | 0.0% |
| 1993 Q4 | 1.7 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 67.75% |
| Addus HomeCare Corporation | 175.18 Million USD | -178.118% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -388.836% |
| American Oncology Network, Inc. | 128.32 Million USD | -279.671% |
| Astrana Health, Inc. | 321.01 Million USD | -51.773% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 67.502% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -324.139% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -4371.473% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -9150.294% |
| COMPASS Pathways plc | 33.04 Million USD | -1374.169% |
| DocGo Inc. | 46.49 Million USD | -947.834% |
| The Ensign Group, Inc. | 1.87 Billion USD | 73.964% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -1016.565% |
| InnovAge Holding Corp. | 113.03 Million USD | -331.028% |
| Assure Holdings Corp. | 14.8 Million USD | -3190.868% |
| The Joint Corp. | 16.73 Million USD | -2811.371% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 4.663% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -74042.221% |
| ModivCare Inc. | 1.14 Billion USD | 57.265% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -146406.873% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -10795.6% |
| Option Care Health, Inc. | 1.16 Billion USD | 58.23% |
| P3 Health Partners Inc. | 124.64 Million USD | -290.893% |
| P3 Health Partners Inc. | 124.64 Million USD | -290.893% |
| The Pennant Group, Inc. | 329.63 Million USD | -47.805% |
| Surgery Partners, Inc. | 3.06 Billion USD | 84.086% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -196275.296% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | -306.638% |
| The Oncology Institute, Inc. | 119.81 Million USD | -306.638% |